IKT logo
IKT

Inhibikase Therapeutics Inc

Biotechnology

Inhibikase Therapeutics Inc (IKT) Earnings

Last reported
May 12, 2026
EPS estimate
-$0.11
EPS actual
—
Revenue est.
—
Revenue actual
—